Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study.
Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2007 Oct 10; 25(29):4622-7.